Rationale, design, and methods for the Medical Optimization and Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD) study

• Váldodahkkit: Diane C. Berry (Dahkki), Sonia Davis Thomas (Dahkki), Karen F. Dorman (Dahkki), Amber Rose Ivins (Dahkki), Maria de los Angeles Abreu (Dahkki), Laura Young (Dahkki), Kim Boggess (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2018-12-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Annually in the US, over 100,000 pregnant women with overt type 2 diabetes give birth. Strict maternal glycemic control is the key to optimizing infant outcomes. Medical treatment of type 2 diabetes in pregnancy is generally restricted to insulin, as data on the safety and effica...